Brett Giffin Net Worth & Insider Trades
Brett Giffin - Chief Commercial Officer, T2 Biosystems, Inc
What is Brett Giffin's Net Worth?
The current estimated net worth of T2 Biosystems, Inc's Chief Commercial Officer, Brett Giffin, is estimated to be about $61.81K . Brett Giffin owns about 841 units of T2 Biosystems, Inc common stock. In the last year at T2 Biosystems, Inc, Brett Giffin has sold an estimated value of $2.67K worth.
What is Brett Giffin's Past Insider Trading?
Brett Giffin's largest purchase order was 10,600 units , worth over $5.18K on April 11, 2022. Brett Giffin's largest sale order was 1,292 units , worth over $2.32K on November 22, 2022. In total, Brett Giffin has made about 6 transactions over a year of their time at T2 Biosystems, Inc. Brett Giffin usually trades in November and March, with the busiest year in 2022. The most recent transaction was a sale order of 537 units , worth over $349.05 on March 9, 2023.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Brett Giffin
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What is Brett Giffin's' Mailing Address?
- Mailing address is 101 Hartwell Ave. Lexington MA 02421 MA
T2 Biosystems, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| John Sperzel, | 2020 | $490,705 | - | - | $2,571,384 | $393,750 | $3,000 | $3,458,839 |
| John McDonough, | 2020 | $72,906 | - | $74,999 | - | - | $1,022,182 | $1,170,087 |
| John McDonough, | 2019 | $550,000 | - | $372,000 | $478,728 | $233,750 | $3,000 | $1,637,478 |
| Alec Barclay, | 2020 | $340,000 | - | $25,675 | $38,621 | $234,600 | $952 | $639,848 |
| Alec Barclay, | 2019 | $337,500 | $35,000 | $111,600 | $348,834 | $102,000 | $2,900 | $937,834 |
| Anthony Pare, | 2020 | $325,000 | - | $20,738 | $159,763 | $185,250 | $3,000 | $693,751 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1492674/000119312521161531/d23237ddef14a.htm
What are T2 Biosystems, Inc's Past Insider Trades?
T2 Biosystems, Inc's most recent insider trade came on September 29, 2023 by CR Group Lp, Crg Partners Iii Lp, Crg Partners Iii Parallel Fund A Lp, Crg Partners Iii Cayman Unlev Aiv I Lp and Crg Partners Iii Cayman Lev Aiv I Lp who sold 13,130,147 units worth $2.27M . In the last 9 years, insiders at T2 Biosystems, Inc have sold an estimated value of $21.95M and bought an estimated value of $60.75M worth of shares. Insider trading is most common in June, with the busiest year in 2015. The most active traders at the company are Thomas Lowery, Chief Scientific Officer, David Elsbree, and Terrence Michael Gibbs, General Counsel .
T2 Biosystems, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||